Literature DB >> 2501354

Investigation of atypical western blot (immunoblot) reactivity involving core proteins of human immunodeficiency virus type.

S L Josephson1, N S Swack, M T Ramirez, W J Hausler.   

Abstract

Serum specimens which originally exhibited a narrow (indeterminate) 24-kilodalton core protein (p24) or p24/p55 pattern of reactivity with human immunodeficiency virus (HIV) in the Western blot (immunoblot) test were studied to gather information on antibody specificity. A total of 12 specimens were initially reevaluated with an indirect immunofluorescence assay (IFA), three enzyme-linked immunosorbent assays (ELISAs), and Western blot analyses. Five of the specimens were IFA positive and contained anti-gp160/gp120 antibodies which were observed only when an HIV Western blot antigen rich in gp160 and gp120 was used. The remaining seven serum specimens were nonreactive by IFA and showed variable reactivity in HIV antibody ELISAs. The specimens did not cross-react with core antigens for human T-cell leukemia virus types 1 and 2 or contain detectable levels of HIV p24 antigen. The p24/p55 reactivity of six of the seven indeterminate specimens could be reduced or eliminated by preincubating the specimens with disrupted, HIV-infected H9 cells but not with uninfected H9 cells. The six specimens also exhibited discernible reactivity with recombinant HIV p24 antigen. When an additional 23 indeterminate specimens were assayed, all of the serum specimens were nonreactive by IFA while 65% (15 of 23) showed various degrees of reactivity with the recombinant p24 protein. There was no indication that any of the HIV core antibody reactivity was caused by HIV infection. Indeterminate results for five patients with specific p24 reactivity, who were retested after a period of weeks or months, remained indeterminate for HIV antibody with no significant change in ELISA or Western blot reactivity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2501354      PMCID: PMC267457          DOI: 10.1128/jcm.27.5.932-937.1989

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Immunological properties of the Gag protein p24 of the acquired immunodeficiency syndrome retrovirus (human T-cell leukemia virus type III).

Authors:  M G Sarngadharan; L Bruch; M Popovic; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

2.  Follow-up testing and notification of anti-HIV Western blot atypical (indeterminant) donors.

Authors:  S Kleinman; L Fitzpatrick; K Secord; D Wilke
Journal:  Transfusion       Date:  1988 May-Jun       Impact factor: 3.157

3.  Viral envelope protein of HTLV-III is the major target antigen for antibodies in hemophiliac patients.

Authors:  L Kitchen; G Malone; S Orgad; F Barin; R Zaizov; B Ramot; E Gazit; J Kreiss; M Leal; I Wichmann
Journal:  J Infect Dis       Date:  1986-04       Impact factor: 5.226

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Blood donations reactive for HIV in Western blot, but non-infective in culture and recipients of blood.

Authors:  C L van der Poel; H W Reesink; T Tersmette; P N Lelie; H Huisman; F Miedema
Journal:  Lancet       Date:  1986-09-27       Impact factor: 79.321

6.  False-positive Western blot reactions to human immunodeficiency virus in blood donors.

Authors:  A M Couroucé; J Y Muller; D Richard
Journal:  Lancet       Date:  1986-10-18       Impact factor: 79.321

7.  Comparison of detection of antibody to the acquired immune deficiency syndrome virus by enzyme immunoassay, immunofluorescence, and Western blot methods.

Authors:  D Gallo; J L Diggs; G R Shell; P J Dailey; M N Hoffman; J L Riggs
Journal:  J Clin Microbiol       Date:  1986-06       Impact factor: 5.948

8.  Variations in Western blot banding patterns of human T-cell lymphotropic virus type III/lymphadenopathy-associated virus.

Authors:  D S Burke; R R Redfield; P Putman; S S Alexander
Journal:  J Clin Microbiol       Date:  1987-01       Impact factor: 5.948

9.  Human T-cell lymphotropic virus type III: immunologic characterization and primary structure analysis of the major internal protein, p24.

Authors:  J M Casey; Y Kim; P R Andersen; K F Watson; J L Fox; S G Devare
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

10.  Human immunodeficiency virus infection in two cohorts of homosexual men: neutralising sera and association of anti-gag antibody with prognosis.

Authors:  J N Weber; P R Clapham; R A Weiss; D Parker; C Roberts; J Duncan; I Weller; C Carne; R S Tedder; A J Pinching
Journal:  Lancet       Date:  1987-01-17       Impact factor: 79.321

View more
  8 in total

Review 1.  Frequency, causes, and new challenges of indeterminate results in Western blot confirmatory testing for antibodies to human immunodeficiency virus.

Authors:  Ming Guan
Journal:  Clin Vaccine Immunol       Date:  2007-04-04

2.  Reactivity patterns and infection status of serum samples with indeterminate Western immunoblot tests for antibody to human immunodeficiency virus type 1.

Authors:  E Ramirez; P Uribe; D Escanilla; G Sanchez; R T Espejo
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

Review 3.  Laboratory tests for detection of human immunodeficiency virus type 1 infection.

Authors:  N F Nuwayhid
Journal:  Clin Diagn Lab Immunol       Date:  1995-11

4.  Retrovirus in salivary glands from patients with Sjögren's syndrome.

Authors:  S Yamano; J N Renard; F Mizuno; Y Narita; Y Uchida; H Higashiyama; H Sakurai; I Saito
Journal:  J Clin Pathol       Date:  1997-03       Impact factor: 3.411

5.  Characterization of antibodies reacting with HIV gag proteins occasionally found in the serum of non-infected subjects.

Authors:  P Bürgisser; P C Frei
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

6.  Immune response to a major epitope of p24 during infection with human immunodeficiency virus type 1 and implications for diagnosis and prognosis.

Authors:  B Janvier; A Baillou; P Archinard; M Mounier; B Mandrand; A Goudeau; F Barin
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

7.  Comparative humoral responses to human immunodeficiency virus type 1-p24gag linear B-cell epitopes among individuals showing atypical western immunoblotting reactions and implications for diagnosis.

Authors:  J C Lallement; J P Vendrell; P Corbeau; J Ducos; M Segondy; A Escande; V Robert-Hebmann; F Jean; J Reynes; A Serre
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

8.  Anti-human immunodeficiency virus type 1 antibodies of noninfected subjects are not related to autoantibodies occurring in systemic diseases.

Authors:  R Kämmerer; P Bürgisser; P C Frei
Journal:  Clin Diagn Lab Immunol       Date:  1995-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.